Header Logo

Connection

SUSAN HILSENBECK to Patient Selection

Back to Details
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Patient Selection.
SUSAN HILSENBECK
Connection Strength
0.106
Patient Selection
  1. Modernizing Eligibility Criteria for Molecularly Driven Trials. J Clin Oncol. 2015 Sep 01; 33(25):2815-20.
    View in: PubMed
    Score: 0.093
  2. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Res Treat. 2008 Mar; 108(2):233-40.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.